New research suggests aspirin taken intravenously may be an effective treatment for migraine patients in the U.S. The method is common in Europe.
A study was done involving 168 patients suffering chronic daily headaches. In a study, two thirds of the patients reported a decrease in pain following the treatment, according to the study published Monday in the American Academy of Neurology.
The study shows hope for chronic migraine sufferers – who often have to turn to powerful and addictive alternatives when normal options don’t work.